(Q47730354)

5 February 2018

title

Migration of the activation peptide of thrombin-activatable fibrinolysis inhibitor (TAFI) during SDS-polyacrylamide gel electrophoresis. (English)

1 reference

5 February 2018

polyacrylamide gel electrophoresis

main subject

1 reference

4

1 reference

5 February 2018

author name string

Guimarães AH

1

1 reference

5 February 2018

Barrett-Bergshoeff MM

2

1 reference

5 February 2018

Gils A

3

1 reference

5 February 2018

Rijken DC

5

1 reference

5 February 2018

publication date

1 May 2004

1 reference

5 February 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

5 February 2018

volume

2

1 reference

5 February 2018

issue

5

1 reference

5 February 2018

page(s)

780-784

1 reference

5 February 2018

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

Human procarboxypeptidase B: three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor (TAFI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

Development of a genotype 325-specific proCPU/TAFI ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00703.X

10.1111/J.1538-7836.2004.00703.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

15099285

1 reference

5 February 2018